1-17075721-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_007365.3(PADI2):c.1413C>T(p.His471His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.005 in 1,614,014 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0035 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0052 ( 27 hom. )
Consequence
PADI2
NM_007365.3 synonymous
NM_007365.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.311
Genes affected
PADI2 (HGNC:18341): (peptidyl arginine deiminase 2) This gene encodes a member of the peptidyl arginine deiminase family of enzymes, which catalyze the post-translational deimination of proteins by converting arginine residues into citrullines in the presence of calcium ions. The family members have distinct substrate specificities and tissue-specific expression patterns. The type II enzyme is the most widely expressed family member. Known substrates for this enzyme include myelin basic protein in the central nervous system and vimentin in skeletal muscle and macrophages. This enzyme is thought to play a role in the onset and progression of neurodegenerative human disorders, including Alzheimer disease and multiple sclerosis, and it has also been implicated in glaucoma pathogenesis. This gene exists in a cluster with four other paralogous genes. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 1-17075721-G-A is Benign according to our data. Variant chr1-17075721-G-A is described in ClinVar as [Benign]. Clinvar id is 773390.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.311 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PADI2 | NM_007365.3 | c.1413C>T | p.His471His | synonymous_variant | 12/16 | ENST00000375486.9 | NP_031391.2 | |
PADI2 | XM_017000148.3 | c.468C>T | p.His156His | synonymous_variant | 4/8 | XP_016855637.1 | ||
PADI2 | XM_047442975.1 | c.*67C>T | 3_prime_UTR_variant | 11/11 | XP_047298931.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PADI2 | ENST00000375486.9 | c.1413C>T | p.His471His | synonymous_variant | 12/16 | 1 | NM_007365.3 | ENSP00000364635.4 | ||
PADI2 | ENST00000466151.1 | n.1040C>T | non_coding_transcript_exon_variant | 4/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00350 AC: 532AN: 152180Hom.: 3 Cov.: 32
GnomAD3 genomes
AF:
AC:
532
AN:
152180
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00324 AC: 814AN: 251186Hom.: 0 AF XY: 0.00334 AC XY: 453AN XY: 135794
GnomAD3 exomes
AF:
AC:
814
AN:
251186
Hom.:
AF XY:
AC XY:
453
AN XY:
135794
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00516 AC: 7537AN: 1461716Hom.: 27 Cov.: 39 AF XY: 0.00499 AC XY: 3631AN XY: 727170
GnomAD4 exome
AF:
AC:
7537
AN:
1461716
Hom.:
Cov.:
39
AF XY:
AC XY:
3631
AN XY:
727170
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00350 AC: 533AN: 152298Hom.: 3 Cov.: 32 AF XY: 0.00334 AC XY: 249AN XY: 74464
GnomAD4 genome
AF:
AC:
533
AN:
152298
Hom.:
Cov.:
32
AF XY:
AC XY:
249
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at